Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

NARecruitingINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

November 17, 2025

Study Completion Date

November 17, 2028

Conditions
Leukemia,Myeloid, Chronic
Interventions
BIOLOGICAL

Blood and bone marrow sample

"Individual biological aging determined by DNA methylation analysis will be assessed at D0, M3 and M12.~An optional bone marrow sample will be taken during the myelogram performed at diagnosis.~Individual fragility and quality of life will be assessed using geriatric tools at D0, M6, M12, M24 and M36"

Trial Locations (17)

63000

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand

Unknown

RECRUITING

CHU Annecy-Genevois, Annecy

NOT_YET_RECRUITING

Institut Bergonié, Bordeaux

RECRUITING

CHU Caen, Caen

NOT_YET_RECRUITING

CHU Créteil, Créteil

NOT_YET_RECRUITING

CHU Grenoble Alpes, Grenoble

RECRUITING

Centre Hospitalier Emile Roux, Le Puy-en-Velay

NOT_YET_RECRUITING

CHRU Lille, Lille

RECRUITING

CHU Limoges, Limoges

WITHDRAWN

Centre Léon Bérard, Lyon

RECRUITING

Institut Paoli-Calmettes, Marseille

RECRUITING

CHU Nancy, Nancy

RECRUITING

Groupe Hospitalier Paris Saclay - Site de Bicêtre, Paris

RECRUITING

CHU Rennes, Rennes

RECRUITING

CHU Saint-Etienne, Saint-Etienne

RECRUITING

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse

RECRUITING

CHU Versailles, Versailles

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER